Endocrine therapies, such as tamoxifen, fulvestrant, and aromatase inhibitors, which target estrogen or ER, are useful in breast cancer treatment (Jelovac et al., 2005; Jordan and Brodie, 2007). Here, ESR1 is linked to breast cancer.